"As compared to the 27th March 2018 Sales Pipeline update, there has been some further progress in commercial development activities, particularly among customers performing test evaluations. This is critically important as it underscores the Company’s expansion program and the plan to move to an expediated Phase 2 expansion decision. As often communicated, the Company is not demand-constrained but is production-constrained, and the primary focus remains on remedying this as quickly as possible"
CFO Price at posting:
20.0¢ Sentiment: Hold Disclosure: Held